MedTrace Logo

Magnesium Sulfate vs Placebo for Placental Abruption

NCT00186069 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2018-01-02

Study results available
· View outcomes & findings →

Summary

To evaluate the safety and efficacy of magnesium sulfate for preterm suspected abruption.

Conditions

  • Abruptio Placentae

Interventions

DRUG

Magnesium Sulfate

Magnesium Sulfate 4 gram bolus, followed by a maintenance dose at 2 grams per hour. Rate increases up to 4 grams per hour may be administered per physician discretion.

OTHER

Normal Saline

Normal Saline infusion of 4 gram bolus, followed by 2 grams per hour with rate increases up to 4 grams per hour per physician discretion.

Sponsors & Collaborators

Principal Investigators

  • Yasser Y El-Sayed, MD · Stanford University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-03-31
Primary Completion
2014-06-30
Completion
2017-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00186069 on ClinicalTrials.gov